0001638599-18-000721.txt : 20180703
0001638599-18-000721.hdr.sgml : 20180703
20180703141404
ACCESSION NUMBER: 0001638599-18-000721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rowe Michael M
CENTRAL INDEX KEY: 0001744774
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 18936160
MAIL ADDRESS:
STREET 1: C/O EYENOVIA, INC.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
4
1
doc4_5497.xml
PRIMARY DOCUMENT
X0306
4
2018-07-02
0
0001682639
EYENOVIA, INC.
EYEN
0001744774
Rowe Michael M
C/O EYENOVIA, INC.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
0
1
0
0
Vice President of Marketing
Common Stock, par value $.0001
200
D
Stock Option (right to buy)
6.30
2018-07-02
4
A
0
60000
0.00
A
2028-07-02
Common Stock
60000
60000
D
The option becomes exercisable as to 1,666 shares on August 2, 2018, and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2018-07-03